Invest now
Sotac Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹90.05(0.00%)October 1, 2026 09:33:07 AM IST
- NSE
- BSE
- Vol : 0 (NSE + BSE)Last 20 day avg : 10.26 K
Sotac Pharmaceuticals is trading 0.00% upper at Rs 90.05 as compared to its last closing price. Sotac Pharmaceuticals has been trading in the price range of 90.05 & 90.05. Sotac Pharmaceuticals has given -26.85% in this year & 0.00% in the last 5 days. Sotac Pharmaceuticals has TTM P/E ratio 20.93 as compared to the sector P/E of 33.86.Listed peers of Sotac Pharmaceuticals include Sun Pharmaceutical Industries (0.06%), Divi's Laboratories (1.76%), Torrent Pharmaceuticals (0.37%).The Mutual Fund holding in Sotac Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Sotac Pharmaceuticals was at 16.79% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 06 Oct 2026, 12:37 PM IST
- BetaMedium volatility0.95Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.64The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.22Annual dividends as a percentage of the stock price.
- PEG RatioIndicates Fair Valuation1.99The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Sotac Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,783.05 | 0.06 | 4,27,803.34 | 37.74 | 5.45 | 0.84 | 0.47 |
| Divi's Laboratories | 9,375.00 | 1.76 | 2,48,876.79 | 91.30 | 14.29 | 0.33 | 0.03 |
| Torrent Pharmaceuticals | 4,772.95 | 0.37 | 1,81,541.18 | 74.67 | 19.73 | 0.78 | 141.16 |
| Cipla | 1,336.00 | 0.15 | 1,07,929.88 | 27.26 | 3.29 | 0.93 | 1.11 |
| Laurus Labs | 2,008.30 | 2.26 | 1,08,510.91 | 114.07 | 19.22 | 0.11 | 13.64 |
Sotac Pharmaceuticals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-26 | Audited Results, Dividend & Others |
| 2025-11-12 | Quarterly Results & Others |
| 2025-05-28 | Audited Results, Dividend & Others |
| 2024-10-29 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
About the company Sotac Pharmaceuticals
- IndustryBiotechnology & Drugs
- ISININE0O2D01012
- BSE Code
- NSE CodeSOTAC
Sotac Pharmaceuticals Ltd is an India-based pharmaceutical company. The Company manufactures pharmaceutical products such as tablets, capsules (general & beta-lactum), oral liquid, dry syrup and external preparations. Its services include contract manufacturing, loan license, formulation and development (F&D) and research and development (R&D). Its products portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacids, anti-ulcerants, proton pump inhibitors (PPIs), anti-emetics, cardiac care, anti-hypertensives, analgesics, anti-pyretics, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (IP-Lactams & Non-IP-Lactams), anti-fungal, and cephalosporin products. It also manufactures nutraceuticals products and food products on contract-manufacturing basis. Its subsidiaries include Sotac Healthcare Private Limited, Sotac Research Private Limited, and Sotac Lifesciences Private Limited.
Sotac Pharmaceuticals Share Price FAQs
Sotac Pharmaceuticals is trading at 90.05 as on Thu Oct 01 2026 04:03:07. This is 0.00% upper as compared to its previous closing price of 90.05.
The market capitalization of Sotac Pharmaceuticals is 99.51 Cr as on Thu Oct 01 2026 04:03:07.
The 52 wk high for Sotac Pharmaceuticals is 139.65 whereas the 52 wk low is 86.00
Sotac Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 20.93
- Sector P/E: 33.86
- Dividend Yield: 0.22%
- D/E ratio: 0.64
Sotac Pharmaceuticals reported a net profit of 5.77 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Sotac Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.